Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

673 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis.
Tavenier AH, Mehran R, Chiarito M, Cao D, Pivato CA, Nicolas J, Beerkens F, Nardin M, Sartori S, Baber U, Angiolillo DJ, Capodanno D, Valgimigli M, Hermanides RS, van 't Hof AWJ, Ten Berg JM, Chang K, Kini AS, Sharma SK, Dangas G. Tavenier AH, et al. Among authors: capodanno d. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):492-502. doi: 10.1093/ehjcvp/pvab068. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34459481
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registry.
Tamburino C, Di Salvo ME, Capodanno D, Capranzano P, Parisi R, Mirabella F, Scardaci F, Ussia G, Galassi AR, Fiscella D, Mehran R, Dangas G. Tamburino C, et al. Among authors: capodanno d. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):243-8. doi: 10.1002/ccd.21750. Catheter Cardiovasc Interv. 2009. PMID: 19156896
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, Dangas G, Corcos T, Prati F. Tamburino C, et al. Among authors: capodanno d. JACC Cardiovasc Interv. 2009 Mar;2(3):197-204. doi: 10.1016/j.jcin.2008.12.006. JACC Cardiovasc Interv. 2009. PMID: 19463426 Free article. Clinical Trial.
Platelet thrombin receptor antagonism and atherothrombosis.
Angiolillo DJ, Capodanno D, Goto S. Angiolillo DJ, et al. Among authors: capodanno d. Eur Heart J. 2010 Jan;31(1):17-28. doi: 10.1093/eurheartj/ehp504. Epub 2009 Nov 30. Eur Heart J. 2010. PMID: 19948715 Free PMC article. Review.
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabaté M, Ferreiro JL, Ueno M, Jimenez-Quevedo P, Alfonso F, Bass TA, Macaya C, Fernandez-Ortiz A. Angiolillo DJ, et al. Among authors: capodanno d. J Am Coll Cardiol. 2010 Mar 16;55(11):1139-46. doi: 10.1016/j.jacc.2009.10.043. J Am Coll Cardiol. 2010. PMID: 20223369 Free article.
Impact of race and gender on antithrombotic therapy.
Capodanno D, Angiolillo DJ. Capodanno D, et al. Thromb Haemost. 2010 Sep;104(3):471-84. doi: 10.1160/TH10-04-0232. Epub 2010 Jul 20. Thromb Haemost. 2010. PMID: 20664898 Review.
673 results